Dr. Christopher David Codispoti, MD, PhD

Dr. Codispoti practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Codispoti's NPI, 1922219211, was assigned on May 25, 2007. Dr. Codispoti graduated from University Of Cincinnati College Of Medicine in 2003. Dr. Codispoti's Texas license number on file is V3267.

Dr. Codispoti's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Codispoti's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. The medical group on file is UT Physicians. Dmand AI also links Dr. Codispoti to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Codispoti practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Codispoti's primary specialty in the NPI Registry, under taxonomy code 207RA0201X. Dr. Codispoti is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Codispoti's licenses on file in 4 states: Texas, Illinois, Ohio and Pennsylvania.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies and hives among the conditions Dr. Codispoti treats.

CMS data shows 42 Medicare services from Dr. Codispoti across 1 procedure code in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $2,843 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Codispoti in 2024. The largest group is 65 to 74, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Codispoti's median patient age at 35, with 64% women.

In 2024, Dr. Codispoti wrote 698 Medicare Part D claims for 88 patients. 60% of them were for generic drugs. CMS names the drug for 561 of them, across 14 drugs with 11 or more claims each, at $521,959 in total drug cost. In 2023, CMS named 707 claims across 21 drugs.

Dr. Codispoti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 44 papers to Dr. Codispoti, published from 2009 to 2025. 2017 was the busiest year, with 6. The most frequent topics are Asthma, Rhinitis and Sinusitis. Dr. Codispoti has published most often in Ann Allergy Asthma Immunol. Dr. Codispoti's most frequent co-authors are Mahboobeh Mahdavinia, Ryan M. Dunn, MD and Jill Starzyk Jeffe, MD.

CMS Open Payments shows 75 general payments to Dr. Codispoti from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $686.

Dmand AI lists 1 award for Dr. Codispoti, most recently CMS Stage 1 EHR in 2013.

Dr. Codispoti graduated from University Of Cincinnati College Of Medicine in 2003.

Dr. Codispoti is in network with 20 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.